{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T23:32:03Z","timestamp":1791070323541,"version":"4.1.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2014,4,22]],"date-time":"2014-04-22T00:00:00Z","timestamp":1398124800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1038\/bjc.2014.153","type":"journal-article","created":{"date-parts":[[2014,4,22]],"date-time":"2014-04-22T16:32:07Z","timestamp":1398184327000},"page":"2514-2523","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Tumour-initiating capacity is independent of epithelial\u2013mesenchymal transition status in breast cancer cell lines"],"prefix":"10.1038","volume":"110","author":[{"given":"G","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Q","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Q","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,4,22]]},"reference":[{"key":"BFbjc2014153_CR1","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1097\/01.LAB.0000059927.97515.FD","volume":"83","author":"ML Ackland","year":"2003","unstructured":"Ackland ML, Newgreen DF, Fridman M, Waltham MC, Arvanitis A, Minichiello J, Price JT, Thompson EW (2003) Epidermal growth factor-induced epithelio-mesenchymal transition in human breast carcinoma cells. Lab Invest 83: 435\u2013448.","journal-title":"Lab Invest"},{"key":"BFbjc2014153_CR2","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1172\/JCI38019","volume":"119","author":"H Acloque","year":"2009","unstructured":"Acloque H, Adams MS, Fishwick K, Bronner-Fraser M, Nieto MA (2009) Epithelial-mesenchymal transitions: the importance of changing cell state in development and disease. J Clin Invest 119: 1438\u20131449.","journal-title":"J Clin Invest"},{"key":"BFbjc2014153_CR3","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.copbio.2007.10.007","volume":"18","author":"LE Ailles","year":"2007","unstructured":"Ailles LE, Weissman IL (2007) Cancer stem cells in solid tumors. Curr Opin Biotechnol 18: 460\u2013466.","journal-title":"Curr Opin Biotechnol"},{"key":"BFbjc2014153_CR4","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.gde.2003.11.007","volume":"14","author":"M Al-Hajj","year":"2004","unstructured":"Al-Hajj M, Becker MW, Wicha M, Weissman I, Clarke MF (2004) Therapeutic implications of cancer stem cells. Curr Opin Genet Dev 14: 43\u201347.","journal-title":"Curr Opin Genet Dev"},{"key":"BFbjc2014153_CR5","doi-asserted-by":"publisher","first-page":"3983","DOI":"10.1073\/pnas.0530291100","volume":"100","author":"M Al-Hajj","year":"2003","unstructured":"Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF (2003) Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 100: 3983\u20133988.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFbjc2014153_CR6","doi-asserted-by":"publisher","first-page":"2889","DOI":"10.1158\/0008-5472.CAN-12-0212","volume":"72","author":"D Albino","year":"2012","unstructured":"Albino D, Longoni N, Curti L, Mello-Grand M, Pinton S, Civenni G, Thalmann G, D'Ambrosio G, Sarti M, Sessa F, Chiorino G, Catapano CV, Carbone GM (2012) ESE3\/EHF controls epithelial cell differentiation and its loss leads to prostate tumors with mesenchymal and stem-like features. Cancer Res 72: 2889\u20132900.","journal-title":"Cancer Res"},{"key":"BFbjc2014153_CR7","doi-asserted-by":"publisher","first-page":"17954","DOI":"10.1074\/jbc.M113.475277","volume":"288","author":"N Balanis","year":"2013","unstructured":"Balanis N, Wendt MK, Schiemann BJ, Wang Z, Schiemann WP, Carlin CR (2013) Epithelial to mesenchymal transition promotes breast cancer progression via a fibronectin-dependent STAT3 signaling pathway. J Biol Chem 288: 17954\u201317967.","journal-title":"J Biol Chem"},{"key":"BFbjc2014153_CR8","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.semcdb.2008.02.001","volume":"19","author":"B Baum","year":"2008","unstructured":"Baum B, Settleman J, Quinlan MP (2008) Transitions between epithelial and mesenchymal states in development and disease. Semin Cell Dev Biol 19: 294\u2013308.","journal-title":"Semin Cell Dev Biol"},{"key":"BFbjc2014153_CR9","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s10911-010-9175-z","volume":"15","author":"T Blick","year":"2010","unstructured":"Blick T, Hugo H, Widodo E, Waltham M, Pinto C, Mani SA, Weinberg RA, Neve RM, Lenburg ME, Thompson EW (2010) Epithelial mesenchymal transition traits in human breast cancer cell lines parallel the CD44(hi\/)CD24(lo\/\u2212) stem cell phenotype in human breast cancer. J Mammary Gland Biol Neoplasia 15: 235\u2013252.","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"BFbjc2014153_CR10","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1172\/JCI59218","volume":"122","author":"T Celia-Terrassa","year":"2012","unstructured":"Celia-Terrassa T, Meca-Cortes O, Mateo F, de Paz AM, Rubio N, Arnal-Estape A, Ell BJ, Bermudo R, Diaz A, Guerra-Rebollo M, Lozano JJ, Estaras C, Ulloa C, Alvarez-Simon D, Mila J, Vilella R, Paciucci R, Martinez-Balbas M, de Herreros AG, Gomis RR, Kang Y, Blanco J, Fernandez PL, Thomson TM (2012) Epithelial-mesenchymal transition can suppress major attributes of human epithelial tumor-initiating cells. J Clin Invest 122: 1849\u20131868.","journal-title":"J Clin Invest"},{"key":"BFbjc2014153_CR11","doi-asserted-by":"publisher","first-page":"4147","DOI":"10.1158\/0008-5472.CAN-12-4085","volume":"73","author":"CC Chang","year":"2013","unstructured":"Chang CC, Hsu WH, Wang CC, Chou CH, Kuo MY, Lin BR, Chen ST, Tai SK, Kuo ML, Yang MH (2013) Connective tissue growth factor activates pluripotency genes and mesenchymal-epithelial transition in head and neck cancer cells. Cancer Res 73: 4147\u20134157.","journal-title":"Cancer Res"},{"key":"BFbjc2014153_CR12","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/ncb2173","volume":"13","author":"CJ Chang","year":"2011","unstructured":"Chang CJ, Chao CH, Xia W, Yang JY, Xiong Y, Li CW, Yu WH, Rehman SK, Hsu JL, Lee HH, Liu M, Chen CT, Yu D, Hung MC (2011) p53 regulates epithelial-mesenchymal transition and stem cell properties through modulating miRNAs. Nat Cell Biol 13: 317\u2013323.","journal-title":"Nat Cell Biol"},{"key":"BFbjc2014153_CR13","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1186\/1476-4598-9-179","volume":"9","author":"YL Chao","year":"2010","unstructured":"Chao YL, Shepard CR, Wells A (2010) Breast carcinoma cells re-express E-cadherin during mesenchymal to epithelial reverting transition. Mol Cancer 9: 179.","journal-title":"Mol Cancer"},{"key":"BFbjc2014153_CR14","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1002\/path.3988","volume":"228","author":"SC Chen","year":"2012","unstructured":"Chen SC, Kung ML, Hu TH, Chen HY, Wu JC, Kuo HM, Tsai HE, Lin YW, Wen ZH, Liu JK, Yeh MH, Tai MH (2012) Hepatoma-derived growth factor regulates breast cancer cell invasion by modulating epithelial\u2014mesenchymal transition. J Pathol 228: 158\u2013169.","journal-title":"J Pathol"},{"key":"BFbjc2014153_CR15","doi-asserted-by":"publisher","first-page":"10433","DOI":"10.1158\/0008-5472.CAN-10-2638","volume":"70","author":"SH Chiou","year":"2010","unstructured":"Chiou SH, Wang ML, Chou YT, Chen CJ, Hong CF, Hsieh WJ, Chang HT, Chen YS, Lin TW, Hsu HS, Wu CW (2010) Coexpression of Oct4 and Nanog enhances malignancy in lung adenocarcinoma by inducing cancer stem cell-like properties and epithelial-mesenchymal transdifferentiation. Cancer Res 70: 10433\u201310444.","journal-title":"Cancer Res"},{"key":"BFbjc2014153_CR16","doi-asserted-by":"publisher","first-page":"13820","DOI":"10.1073\/pnas.0905718106","volume":"106","author":"CJ Creighton","year":"2009","unstructured":"Creighton CJ, Li X, Landis M, Dixon JM, Neumeister VM, Sjolund A, Rimm DL, Wong H, Rodriguez A, Herschkowitz JI, Fan C, Zhang X, He X, Pavlick A, Gutierrez MC, Renshaw L, Larionov AA, Faratian D, Hilsenbeck SG, Perou CM, Lewis MT, Rosen JM, Chang JC (2009) Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features. Proc Natl Acad Sci USA 106: 13820\u201313825.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFbjc2014153_CR17","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1002\/ijc.23894","volume":"124","author":"P Dasgupta","year":"2009","unstructured":"Dasgupta P, Rizwani W, Pillai S, Kinkade R, Kovacs M, Rastogi S, Banerjee S, Carless M, Kim E, Coppola D, Haura E, Chellappan S (2009) Nicotine induces cell proliferation, invasion and epithelial-mesenchymal transition in a variety of human cancer cell lines. Int J Cancer 124: 36\u201345.","journal-title":"Int J Cancer"},{"key":"BFbjc2014153_CR18","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1159\/000147846","volume":"156","author":"JA Davies","year":"1996","unstructured":"Davies JA (1996) Mesenchyme to epithelium transition during development of the mammalian kidney tubule. Acta Anat (Basel) 156: 187\u2013201.","journal-title":"Acta Anat (Basel)"},{"key":"BFbjc2014153_CR19","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1002\/ijc.26493","volume":"131","author":"E Devarajan","year":"2012","unstructured":"Devarajan E, Song YH, Krishnappa S, Alt E (2012) Epithelial-mesenchymal transition in breast cancer lines is mediated through PDGF-D released by tissue-resident stem cells. Int J Cancer 131: 1023\u20131031.","journal-title":"Int J Cancer"},{"key":"BFbjc2014153_CR20","doi-asserted-by":"publisher","first-page":"F1202","DOI":"10.1152\/ajprenal.00406.2005","volume":"290","author":"NG Docherty","year":"2006","unstructured":"Docherty NG, O'Sullivan OE, Healy DA, Murphy M, O'Neill AJ, Fitzpatrick JM, Watson RW (2006) TGF-beta1-induced EMT can occur independently of its proapoptotic effects and is aided by EGF receptor activation. Am J Physiol Renal Physiol 290: F1202\u2013F1212.","journal-title":"Am J Physiol Renal Physiol"},{"key":"BFbjc2014153_CR21","doi-asserted-by":"publisher","first-page":"4707","DOI":"10.1038\/onc.2011.181","volume":"30","author":"X Fang","year":"2011","unstructured":"Fang X, Cai Y, Liu J, Wang Z, Wu Q, Zhang Z, Yang CJ, Yuan L, Ouyang G (2011) Twist2 contributes to breast cancer progression by promoting an epithelial-mesenchymal transition and cancer stem-like cell self-renewal. Oncogene 30: 4707\u20134720.","journal-title":"Oncogene"},{"key":"BFbjc2014153_CR22","doi-asserted-by":"publisher","first-page":"281","DOI":"10.3390\/cancers4010281","volume":"4","author":"V Fendrich","year":"2012","unstructured":"Fendrich V, Maschuw K, Waldmann J, Buchholz M, Rehm J, Gress TM, Bartsch DK, Konig A (2012) Epithelial-mesenchymal transition is a critical step in tumorgenesis of pancreatic neuroendocrine tumors. Cancers (Basel) 4: 281\u2013294.","journal-title":"Cancers (Basel)"},{"key":"BFbjc2014153_CR23","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.stem.2007.08.014","volume":"1","author":"C Ginestier","year":"2007","unstructured":"Ginestier C, Hur MH, Charafe-Jauffret E, Monville F, Dutcher J, Brown M, Jacquemier J, Viens P, Kleer CG, Liu S, Schott A, Hayes D, Birnbaum D, Wicha MS, Dontu G (2007) ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 1: 555\u2013567.","journal-title":"Cell Stem Cell"},{"key":"BFbjc2014153_CR24","doi-asserted-by":"publisher","first-page":"e41335","DOI":"10.1371\/journal.pone.0041335","volume":"7","author":"X Han","year":"2012","unstructured":"Han X, Fang X, Lou X, Hua D, Ding W, Foltz G, Hood L, Yuan Y, Lin B (2012) Silencing SOX2 induced mesenchymal-epithelial transition and its expression predicts liver and lymph node metastasis of CRC patients. PLoS One 7: e41335.","journal-title":"PLoS One"},{"key":"BFbjc2014153_CR25","doi-asserted-by":"publisher","first-page":"e47995","DOI":"10.1371\/journal.pone.0047995","volume":"7","author":"E Iorns","year":"2012","unstructured":"Iorns E, Drews-Elger K, Ward TM, Dean S, Clarke J, Berry D, El AD, Lippman M (2012) A new mouse model for the study of human breast cancer metastasis. PLoS One 7: e47995.","journal-title":"PLoS One"},{"key":"BFbjc2014153_CR26","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1172\/JCI39104","volume":"119","author":"R Kalluri","year":"2009","unstructured":"Kalluri R, Weinberg RA (2009) The basics of epithelial-mesenchymal transition. J Clin Invest 119: 1420\u20131428.","journal-title":"J Clin Invest"},{"key":"BFbjc2014153_CR27","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1186\/1471-2407-13-383","volume":"13","author":"J Kim","year":"2013","unstructured":"Kim J, Jeong H, Lee Y, Kim C, Kim H, Kim A (2013) HRG-beta1-driven ErbB3 signaling induces epithelial-mesenchymal transition in breast cancer cells. BMC Cancer 13: 383.","journal-title":"BMC Cancer"},{"issue":"22","key":"BFbjc2014153_CR28","doi-asserted-by":"publisher","first-page":"6679","DOI":"10.1158\/0008-5472.CAN-13-0888","volume":"73","author":"SJ Kim","year":"2013","unstructured":"Kim SJ, Yang KM, Jung Y, Lee JM, Kim W, Cho JK, Jeong J (2013) Loss of TBK1 induces epithelial-mesenchymal transition in the breast cancer cells by ERalpha downregulation. Cancer Res 73 (22): 6679\u20136689.","journal-title":"Cancer Res"},{"key":"BFbjc2014153_CR29","doi-asserted-by":"publisher","first-page":"e12445","DOI":"10.1371\/journal.pone.0012445","volume":"5","author":"D Kong","year":"2010","unstructured":"Kong D, Banerjee S, Ahmad A, Li Y, Wang Z, Sethi S, Sarkar FH (2010) Epithelial to mesenchymal transition is mechanistically linked with stem cell signatures in prostate cancer cells. PLoS One 5: e12445.","journal-title":"PLoS One"},{"key":"BFbjc2014153_CR30","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nprot.2009.22","volume":"4","author":"RH Kutner","year":"2009","unstructured":"Kutner RH, Zhang XY, Reiser J (2009) Production, concentration and titration of pseudotyped HIV-1-based lentiviral vectors. Nat Protoc 4: 495\u2013505.","journal-title":"Nat Protoc"},{"key":"BFbjc2014153_CR31","first-page":"1858","volume":"40","author":"AA Leontovich","year":"2012","unstructured":"Leontovich AA, Zhang S, Quatraro C, Iankov I, Veroux PF, Gambino MW, Degnim A, McCubrey J, Ingle J, Galanis E, D'Assoro AB (2012) Raf-1 oncogenic signaling is linked to activation of mesenchymal to epithelial transition pathway in metastatic breast cancer cells. Int J Oncol 40: 1858\u20131864.","journal-title":"Int J Oncol"},{"key":"BFbjc2014153_CR32","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1093\/jnci\/djn123","volume":"100","author":"X Li","year":"2008","unstructured":"Li X, Lewis MT, Huang J, Gutierrez C, Osborne CK, Wu MF, Hilsenbeck SG, Pavlick A, Zhang X, Chamness GC, Wong H, Rosen J, Chang JC (2008) Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy. J Natl Cancer Inst 100: 672\u2013679.","journal-title":"J Natl Cancer Inst"},{"key":"BFbjc2014153_CR33","doi-asserted-by":"publisher","first-page":"19035","DOI":"10.1073\/pnas.0910009106","volume":"106","author":"M Liu","year":"2009","unstructured":"Liu M, Casimiro MC, Wang C, Shirley LA, Jiao X, Katiyar S, Ju X, Li Z, Yu Z, Zhou J, Johnson M, Fortina P, Hyslop T, Windle JJ, Pestell RG (2009) p21CIP1 attenuates Ras- and c-Myc-dependent breast tumor epithelial mesenchymal transition and cancer stem cell-like gene expression in vivo. Proc Natl Acad Sci USA 106: 19035\u201319039.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFbjc2014153_CR34","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1242\/dev.007047","volume":"135","author":"Y Liu","year":"2008","unstructured":"Liu Y, El-Naggar S, Darling DS, Higashi Y, Dean DC (2008) Zeb1 links epithelial-mesenchymal transition and cellular senescence. Development 135: 579\u2013588.","journal-title":"Development"},{"key":"BFbjc2014153_CR35","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/j.cell.2008.03.027","volume":"133","author":"SA Mani","year":"2008","unstructured":"Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY, Brooks M, Reinhard F, Zhang CC, Shipitsin M, Campbell LL, Polyak K, Brisken C, Yang J, Weinberg RA (2008) The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133: 704\u2013715.","journal-title":"Cell"},{"key":"BFbjc2014153_CR36","first-page":"995","volume":"21","author":"X Meng","year":"2009","unstructured":"Meng X, Wang X, Wang Y (2009) More than 45% of A549 and H446 cells are cancer initiating cells: evidence from cloning and tumorigenic analyses. Oncol Rep 21: 995\u20131000.","journal-title":"Oncol Rep"},{"key":"BFbjc2014153_CR37","doi-asserted-by":"publisher","first-page":"15735","DOI":"10.1073\/pnas.0610444104","volume":"104","author":"Z Miao","year":"2007","unstructured":"Miao Z, Luker KE, Summers BC, Berahovich R, Bhojani MS, Rehemtulla A, Kleer CG, Essner JJ, Nasevicius A, Luker GD, Howard MC, Schall TJ (2007) CXCR7 (RDC1) promotes breast and lung tumor growth in vivo and is expressed on tumor-associated vasculature. Proc Natl Acad Sci USA 104: 15735\u201315740.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFbjc2014153_CR38","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1038\/nature03799","volume":"436","author":"AJ Minn","year":"2005","unstructured":"Minn AJ, Gupta GP, Siegel PM, Bos PD, Shu W, Giri DD, Viale A, Olshen AB, Gerald WL, Massague J (2005) Genes that mediate breast cancer metastasis to lung. Nature 436: 518\u2013524.","journal-title":"Nature"},{"key":"BFbjc2014153_CR39","doi-asserted-by":"publisher","first-page":"e2888","DOI":"10.1371\/journal.pone.0002888","volume":"3","author":"AP Morel","year":"2008","unstructured":"Morel AP, Lievre M, Thomas C, Hinkal G, Ansieau S, Puisieux A (2008) Generation of breast cancer stem cells through epithelial-mesenchymal transition. PLoS One 3: e2888.","journal-title":"PLoS One"},{"key":"BFbjc2014153_CR40","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.devcel.2004.08.003","volume":"7","author":"Y Nakaya","year":"2004","unstructured":"Nakaya Y, Kuroda S, Katagiri YT, Kaibuchi K, Takahashi Y (2004) Mesenchymal-epithelial transition during somitic segmentation is regulated by differential roles of Cdc42 and Rac1. Dev Cell 7: 425\u2013438.","journal-title":"Dev Cell"},{"key":"BFbjc2014153_CR41","doi-asserted-by":"publisher","first-page":"2248","DOI":"10.1038\/bjc.2013.550","volume":"109","author":"PT Nguyen","year":"2013","unstructured":"Nguyen PT, Tsunematsu T, Yanagisawa S, Kudo Y, Miyauchi M, Kamata N, Takata T (2013) The FGFR1 inhibitor PD173074 induces mesenchymal-epithelial transition through the transcription factor AP-1. Br J Cancer 109: 2248\u20132258.","journal-title":"Br J Cancer"},{"key":"BFbjc2014153_CR42","doi-asserted-by":"publisher","first-page":"4020","DOI":"10.4161\/cc.22225","volume":"11","author":"C Oliveras-Ferraros","year":"2012","unstructured":"Oliveras-Ferraros C, Corominas-Faja B, Cufi S, Vazquez-Martin A, Martin-Castillo B, Iglesias JM, Lopez-Bonet E, Martin AG, Menendez JA (2012) Epithelial-to-mesenchymal transition (EMT) confers primary resistance to trastuzumab (Herceptin). Cell Cycle 11: 4020\u20134032.","journal-title":"Cell Cycle"},{"key":"BFbjc2014153_CR43","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1101\/gad.1640608","volume":"22","author":"SM Park","year":"2008","unstructured":"Park SM, Gaur AB, Lengyel E, Peter ME (2008) The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes Dev 22: 894\u2013907.","journal-title":"Genes Dev"},{"key":"BFbjc2014153_CR44","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1093\/jnci\/djj495","volume":"98","author":"TM Phillips","year":"2006","unstructured":"Phillips TM, McBride WH, Pajonk F (2006) The response of CD24(\u2212\/low)\/CD44+ breast cancer-initiating cells to radiation. J Natl Cancer Inst 98: 1777\u20131785.","journal-title":"J Natl Cancer Inst"},{"key":"BFbjc2014153_CR45","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/nrc2620","volume":"9","author":"K Polyak","year":"2009","unstructured":"Polyak K, Weinberg RA (2009) Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat Rev Cancer 9: 265\u2013273.","journal-title":"Nat Rev Cancer"},{"key":"BFbjc2014153_CR46","doi-asserted-by":"publisher","first-page":"5506","DOI":"10.1158\/0008-5472.CAN-05-0626","volume":"65","author":"D Ponti","year":"2005","unstructured":"Ponti D, Costa A, Zaffaroni N, Pratesi G, Petrangolini G, Coradini D, Pilotti S, Pierotti MA, Daidone MG (2005) Isolation and in vitro propagation of tumorigenic breast cancer cells with stem\/progenitor cell properties. Cancer Res 65: 5506\u20135511.","journal-title":"Cancer Res"},{"key":"BFbjc2014153_CR47","doi-asserted-by":"publisher","first-page":"R68","DOI":"10.1186\/bcr2635","volume":"12","author":"A Prat","year":"2010","unstructured":"Prat A, Parker JS, Karginova O, Fan C, Livasy C, Herschkowitz JI, He X, Perou CM (2010) Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer. Breast Cancer Res 12: R68.","journal-title":"Breast Cancer Res"},{"key":"BFbjc2014153_CR48","first-page":"717","volume":"50","author":"JE Price","year":"1990","unstructured":"Price JE, Polyzos A, Zhang RD, Daniels LM (1990) Tumorigenicity and metastasis of human breast carcinoma cell lines in nude mice. Cancer Res 50: 717\u2013721.","journal-title":"Cancer Res"},{"key":"BFbjc2014153_CR49","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1126\/science.1171837","volume":"324","author":"JM Rosen","year":"2009","unstructured":"Rosen JM, Jordan CT (2009) The increasing complexity of the cancer stem cell paradigm. Science 324: 1670\u20131673.","journal-title":"Science"},{"key":"BFbjc2014153_CR50","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1097\/00001622-199711000-00010","volume":"9","author":"B St Croix","year":"1997","unstructured":"St Croix B, Kerbel RS (1997) Cell adhesion and drug resistance in cancer. Curr Opin Oncol 9: 549\u2013556.","journal-title":"Curr Opin Oncol"},{"key":"BFbjc2014153_CR51","doi-asserted-by":"publisher","first-page":"2940","DOI":"10.1038\/onc.2009.180","volume":"28","author":"NJ Sullivan","year":"2009","unstructured":"Sullivan NJ, Sasser AK, Axel AE, Vesuna F, Raman V, Ramirez N, Oberyszyn TM, Hall BM (2009) Interleukin-6 induces an epithelial-mesenchymal transition phenotype in human breast cancer cells. Oncogene 28: 2940\u20132947.","journal-title":"Oncogene"},{"key":"BFbjc2014153_CR52","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1186\/bcr2876","volume":"13","author":"N Takebe","year":"2011","unstructured":"Takebe N, Warren RQ, Ivy SP (2011) Breast cancer growth and metastasis: interplay between cancer stem cells, embryonic signaling pathways and epithelial-to-mesenchymal transition. Breast Cancer Res 13: 211.","journal-title":"Breast Cancer Res"},{"key":"BFbjc2014153_CR53","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.cell.2009.11.007","volume":"139","author":"JP Thiery","year":"2009","unstructured":"Thiery JP, Acloque H, Huang RY, Nieto MA (2009) Epithelial-mesenchymal transitions in development and disease. Cell 139: 871\u2013890.","journal-title":"Cell"},{"key":"BFbjc2014153_CR54","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/j.ccr.2012.09.022","volume":"22","author":"JH Tsai","year":"2012","unstructured":"Tsai JH, Donaher JL, Murphy DA, Chau S, Yang J (2012) Spatiotemporal regulation of epithelial-mesenchymal transition is essential for squamous cell carcinoma metastasis. Cancer Cell 22: 725\u2013736.","journal-title":"Cancer Cell"},{"key":"BFbjc2014153_CR55","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/cr.2009.5","volume":"19","author":"J Xu","year":"2009","unstructured":"Xu J, Lamouille S, Derynck R (2009) TGF-beta-induced epithelial to mesenchymal transition. Cell Res 19: 156\u2013172.","journal-title":"Cell Res"},{"key":"BFbjc2014153_CR56","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1016\/j.devcel.2008.05.009","volume":"14","author":"J Yang","year":"2008","unstructured":"Yang J, Weinberg RA (2008) Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Dev Cell 14: 818\u2013829.","journal-title":"Dev Cell"},{"key":"BFbjc2014153_CR57","doi-asserted-by":"publisher","first-page":"4597","DOI":"10.1158\/0008-5472.CAN-12-1045","volume":"72","author":"J Zhang","year":"2012","unstructured":"Zhang J, Liang Q, Lei Y, Yao M, Li L, Gao X, Feng J, Zhang Y, Gao H, Liu DX, Lu J, Huang B (2012) SOX4 induces epithelial-mesenchymal transition and contributes to breast cancer progression. Cancer Res 72: 4597\u20134608.","journal-title":"Cancer Res"},{"key":"BFbjc2014153_CR58","doi-asserted-by":"publisher","first-page":"3691","DOI":"10.1158\/0008-5472.CAN-06-3912","volume":"67","author":"X Zheng","year":"2007","unstructured":"Zheng X, Shen G, Yang X, Liu W (2007) Most C6 cells are cancer stem cells: evidence from clonal and population analyses. Cancer Res 67: 3691\u20133697.","journal-title":"Cancer Res"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/bjc2014153.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/bjc2014153","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/bjc2014153.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T09:22:20Z","timestamp":1684401740000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bjc2014153"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,22]]},"references-count":58,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["BFbjc2014153"],"URL":"https:\/\/doi.org\/10.1038\/bjc.2014.153","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,22]]},"assertion":[{"value":"28 November 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2014","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2014","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2014","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}